J. Molner Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from J. Molner AS
Access all reports
J. Molner AS is a pharmaceutical company based in Tallinn, Estonia, specializing in the development and provision of generic drugs, particularly sterile injectable and dermatology formulations. The company serves pharmaceutical markets in the United States, Canada, and Europe. In addition to drug development, J. Molner AS offers analytical chemistry services, European market release support, and ongoing stability solutions for its clients. The company is headquartered in Tallinn, Estonia, and its shares are listed on the Nasdaq Tallinn.
Latest articles
The Samsung Co-CEOs: Jong-Hee Han & Young-Hyun Jun
Samsung Electronics' dual-CEO structure, led by Jong-Hee Han and Young-Hyun Jun, is designed to navigate the complexities of its diverse business.
3 Oct 2024
Irwin Jacobs & Andrew Viterbi: Qualcomm's Pioneering Founders
In 1985, Irwin Jacobs and Andrew Viterbi co-founded Qualcomm, a leading company in telecommunications and semiconductor innovation.
3 Oct 2024
AMD: Shaping the Future of Semiconductor Processors
With a background in the U.S. semiconductor evolution, AMD has grown into a powerful player in producing high-quality, competitive processors.
1 Oct 2024
Ticker symbol
MOLNR
Country
EE